Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
Levin
B J L P
BJ
Thompson
G
G
Mitsumoto
Levy H
LH
Kaufmann
P
P
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000401:mortality*; D003627:Data Interpretation, Statistical; D004311:Double-Blind Method; D006801:Humans; D015337:Multicenter Studies as Topic; D018696:Neuroprotective Agents / Q000008:administration & dosage; D017063:Outcome Assessment, Health Care / Q000379:methods*; D010431:Pentoxifylline / Q000008:administration & dosage*; D015990:Placebo Effect; D010919:Placebos; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D017211:Treatment Failure
D018696:Neuroprotective Agents; D010919:Placebos; D010431:Pentoxifylline